Riskpilot← Back to searchSign inGet full accessGENETIC ANALYSIS AS
ASActiveOrg 993373575Ulvenveien 80B, 0581 OsloEngineering activities and related technical consultancy · NACE 7112Est. 200918 employeeswww.genetic-analysis.com
Revenue 2024
NOK 20,7M
-11% vs 2023
EBITDA margin
-43.4%
+51% vs 2023
Equity ratio
53.1%
Financial strength
Net profit 2024
NOK -14,8M
+38% vs 2023
| Revenue | NOK 20,7M | -11% |
| EBITDA | NOK -9M | +51% |
| Net profit | NOK -14,8M | +38% |
| Total assets | NOK 42,4M | -21% |
| Equity | NOK 22,5M | -30% |
| Employees | 18 | — |
Legal name
GENETIC ANALYSIS AS
Org number
993373575
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
26. januar 2009
Share capital
NOK 41 452 224
Employees
18 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Utvikle og selge teknologi for analyser av komplekse genetiske systemer.
Address
Ulvenveien 80B, 0581 Oslo
Phone
+4748321610
Email
info@genetic-analysis.com
Website
www.genetic-analysis.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 969 | 1 277 | 2 856 | 1 881 | 703 | 953 | 2 248 | 802 | 2 933 | 5 420 | 17 833 | 7 754 | 13 379 | 20 747 | 23 164 | 20 684 |
| Staff expenses | −80 | −603 | −107 | −1 976 | −2 071 | −2 722 | −0 | −0 | −0 | −0 | −0 | −14 492 | −16 426 | −22 835 | −25 196 | −23 559 | −19 268 |
| EBITDA | −254 | −2 102 | 28 | −700 | −1 889 | −7 519 | −9 168 | −17 798 | −17 636 | −17 368 | −18 057 | −4 256 | −15 752 | −24 340 | −23 350 | −18 259 | −8 974 |
| Depreciation & amort. | −0 | −4 | −25 | −137 | −310 | −357 | −439 | −818 | −1 769 | −0 | −1 882 | −2 493 | −6 201 | −4 531 | −4 834 | −5 579 | −5 242 |
| EBIT | −254 | −2 106 | 3 | −837 | −2 199 | −7 877 | −9 608 | −18 616 | −19 404 | −17 368 | −19 938 | −6 749 | −21 953 | −28 871 | −28 184 | −23 837 | −14 216 |
| Net financials | 0 | −0 | 12 | 14 | −38 | −498 | −1 409 | −425 | −1 080 | −2 157 | −2 527 | −188 | −182 | −134 | −90 | 19 | −553 |
| Profit before tax | −254 | −2 106 | 14 | −823 | −2 237 | −8 375 | −11 017 | −19 041 | −20 485 | −19 525 | −22 465 | −6 937 | −22 136 | −29 005 | −28 274 | −23 818 | −14 769 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −254 | −2 106 | 14 | −823 | −2 237 | −8 375 | −11 017 | −19 041 | −20 485 | −19 525 | −22 465 | −6 937 | −22 136 | −29 005 | −28 274 | −23 818 | −14 769 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 123 | 175 | 4 490 | 10 834 | 17 503 | 32 709 | 22 098 | 25 226 | 71 779 | 52 448 | 46 449 | 45 590 | 55 619 | 83 490 | 64 425 | 53 490 | 42 377 |
| Equity | −150 | −777 | 3 381 | 9 282 | 11 546 | 25 967 | 8 382 | 20 374 | 54 745 | 45 627 | 38 531 | 33 531 | 46 623 | 72 090 | 44 140 | 31 998 | 22 494 |
| Long-term debt | 0 | 0 | 0 | 0 | 3 814 | 3 635 | 561 | 411 | 2 262 | 2 112 | 2 145 | 2 796 | 1 405 | 1 432 | 7 338 | 5 448 | 16 084 |
| Short-term debt | 274 | 953 | 1 109 | 1 551 | 2 143 | 3 106 | 13 155 | 4 441 | 14 773 | 4 708 | 5 773 | 9 262 | 7 591 | 9 968 | 12 946 | 16 045 | 11 842 |
| Total debt | 274 | 953 | 1 109 | 1 551 | 5 957 | 6 742 | 13 716 | 4 852 | 17 035 | 6 821 | 7 918 | 12 058 | 8 996 | 11 400 | 20 284 | 21 492 | 19 884 |
EBITDA margin
-43.4%
This company
15.8%
Market median
-375% vs market
20082024
Equity ratio
53.1%
This company
38.2%
Market median
+39% vs market
20082024
Return on equity
-65.7%
This company
18.4%
Market median
-457% vs market
20082024
Net profit margin
-71.4%
This company
8.1%
Market median
-981% vs market
20082024
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20082024
Debt / equity
0.88×
This company
0.62×
Market median
+42% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-09-15 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GM Deputy Member | Deputy Member | 2021 | — | — |
RH Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 27.7% | 27.7% | 2022 | |
Citibank, N.A. | Company | 22.5% | 22.5% | 2024 |
| Individual | 21.3% | 21.3% | 2022 | |
Avanza Bank Ab | Company | 10.3% | 10.3% | 2024 |
Muen Invest As | Company | 6.7% | 6.7% | 2024 |
| Individual | 6.2% | 6.2% | 2022 | |
| Individual | 5.7% | 5.7% | 2022 | |
Nordnet Bank Ab | Company | 5.1% | 5.1% | 2024 |
Lucellum As | Company | 4.9% | 4.9% | 2024 |
Ochrino As | Company | 4.2% | 4.2% | 2024 |
S. Munkhaugen As | Company | 3.5% | 3.5% | 2024 |
Molver As | Company | 2.9% | 2.9% | 2024 |
Skandinaviska Enskilda Banken Ab | Company | 2.9% | 2.9% | 2024 |
Ljm As | Company | 2.7% | 2.7% | 2024 |
| Individual | 2.7% | 2.7% | 2024 | |
Ggs Invest As | Company | 2.6% | 2.6% | 2024 |
Per Anton Invest As | Company | 2.4% | 2.4% | 2024 |
Invitrodia As | Company | 2.3% | 2.3% | 2024 |
Stella Invest As | Company | 2.1% | 2.1% | 2024 |
| Individual | 2.1% | 2.1% | 2024 | |
| Individual | 2.1% | 2.1% | 2024 | |
Kagge As | Company | 2.0% | 2.0% | 2024 |
| Individual | 1.5% | 1.5% | 2022 | |
Nordnet Livsforsikring As | Company | 1.1% | 1.1% | 2024 |
Rolfs Holding As | Company | 1.1% | 1.1% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GENETIC ANALYSIS AS 
PROKARIMI ASBoard members of GENETIC ANALYSIS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Giovanni Magni | Deputy Member | 0 companies |
| Ronny Hermansen | Chief Executive Officer | 0 companies |
| Thorvald Helmen Steen | Board of Directors | 0 companies |
| Anne Camilla Huse Bondesson | Board of Directors | 0 companies |
| Jethro Lee Holter | Chairman | 0 companies |
| Staffan Strömberg | Board of Directors | 0 companies |
| Marie Skarbøvik Buchmann | Board of Directors | 0 companies |
| Rune Sørum | Board of Directors | 0 companies |
| Richard Brian Kurtz | Board of Directors | 0 companies |
| Morten Jurs | Chairman | 0 companies |
| Ashok K Shah | Board of Directors | 0 companies |
| Per Nils Jesper Matsson | Chairman | 0 companies |
| Per Ove Öhman | Board of Directors | 0 companies |
| Kathryn Moore Baker | Chairman | 0 companies |
| Andrew George Stapleton | Board of Directors | 0 companies |